Comprehensive analysis of KRT18 as a novel prognostic biomarker and potential target in lung adenocarcinoma
Therefore, KRT18 may serve as a biomarker for the prognosis and diagnosis of LUAD and also represents a potential target for immunotherapy.
Authors
- Zhenpeng Zhu (ORCID: https://orcid.org/0009-0000-4089-3374)
- Xinsheng Wang (ORCID: https://orcid.org/0000-0002-4962-5023)
- Jiajia Xiao (ORCID: https://orcid.org/0000-0002-0074-7345)
- Dandan Xu (ORCID: https://orcid.org/0000-0003-1540-5767)
- Zhicong Yang (ORCID: https://orcid.org/0000-0001-5409-4290)
- Flora Yan (ORCID: https://orcid.org/0000-0003-4775-0784)
- Fan Zhang (ORCID: https://orcid.org/0009-0001-3751-1328)
Institutions
- Hebei North University (CN)
Publication Details
- Journal
- Clinical and Experimental Medicine
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1007/s10238-025-01855-0
- Citations
- 3
- Primary Topic
- Skin and Cellular Biology Research
- Type
- article
- Field-Weighted Citation Impact
- 3.45
Funders
- Health Commission of Hebei Province
- Hebei North University
- Natural Science Foundation of Hebei Province